Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Costs topic
No spam. Unsubscribe anytime.
County insurance consultant warns of rising specialty drug costs; offers compounding pharmacy option
Summary
Jefferson County's insurance consultant reported the health plan's aggregate loss ratio was running near 127% through September and flagged rising spending on specialty drugs (GLP‑1 class). The consultant proposed exploring a local compounding pharmacy to reduce prescription costs, noting tradeoffs with stop‑loss accounting.
Jefferson County's insurance adviser presented an update on the county's self‑insured health plan Nov. 4, reporting aggregate claims through September were running significantly above typical underwriting benchmarks and highlighting prescription drug spending—especially GLP‑1 class drugs—as a driver of rising costs.
"As of September, we're running at a 127%...but we have over 1,200,000 in there," the consultant said when describing the aggregate loss ratio and the county's reserves. He identified costly specialty drugs (Monjaro/Manjaro, Ozempic, Trulicity, Cosentyx) among the top drivers and noted several large active claims (cancer, dialysis) that affect stop‑loss exposure.
To curb pharmacy spending, the consultant outlined a potential arrangement with Mountain View Hospital's compounding pharmacy to prepare certain medications locally. He explained that compounding fills might be paid outside the Blue Cross specialty pharmacy pathway, producing savings for the county but also meaning those dollars would not count toward the specific stop‑loss calculation. He cautioned that if a member later incurred a large medical claim, those saved prescription dollars would not contribute to stop‑loss triggers.
Commissioners asked staff to examine budget implications and to return with analyses, member lists (kept confidential) and options for next steps, including whether to consider switching carriers in the following plan year. No formal action or vendor change was approved at the meeting; staff said they would report back with more detailed cost and member impact information.
